Loading…
Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility
Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or seco...
Saved in:
Published in: | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2016-01, Vol.22 (1), p.14-18 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63 |
---|---|
cites | cdi_FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63 |
container_end_page | 18 |
container_issue | 1 |
container_start_page | 14 |
container_title | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy |
container_volume | 22 |
creator | Kimura, Yumiko Morinaga, Yoshitomo Akamatsu, Norihiko Matsuda, Junichi Yamaryo, Takeshi Kawakami, Kenji Matsuo, Hidenori Kosai, Kosuke Uno, Naoki Hasegawa, Hiroo Yanagihara, Katsunori |
description | Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or secondary care facilities. A total of 128 MRSA isolates (90 skin and soft tissue isolates and 38 blood isolates) were collected at a secondary care facility, Kawatana Medical Center, from 2005 to 2011. Antimicrobial susceptibility testing for anti-MRSA antibiotics and molecular testing for SCC mec and virulence genes ( tst , sec , etb , luk S/F-PV) were performed. Strains positive for luk S/F-PV were analyzed by multilocus sequence typing and phage open-reading frame typing. SCC mec typing in skin and soft tissue isolates revealed that 65.6% had type IV, 22.2% had type II, 8.9% had type I, and 3.3% had type III. In blood isolates, 50.0% had type IV, 47.4% had type II, and 2.6% had type III. Minimum inhibitory concentrations, MIC50 /MIC90 , against vancomycin, teicoplanin, linezolid, and arbekacin increased slightly in SCC mec II isolates from skin and soft tissue. MICs against daptomycin were similar between sites of isolation. SCC mec type II isolates possess tst and sec genes at a greater frequently than SCC mec type IV isolates. Four luk S/F-PV-positive isolates were divided into two clonal patterns and USA300 was not included. In conclusion, SCC mec type IV was dominant in blood, skin, and soft tissue isolates in a secondary care facility in Japan. Because antimicrobial susceptibility varies with the SCC mec type, SCC mec typing of clinical isolates should be monitored in primary or secondary care facilities. |
doi_str_mv | 10.1016/j.jiac.2015.08.011 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1794498849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1341321X15001944</els_id><sourcerecordid>1794498849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63</originalsourceid><addsrcrecordid>eNqNUs2K1jAULaI4P_oCLiRLN61JkzYpiDAM6igDLkbBXUhvbvlS0x-TVPiewlc29RtduBBXN5BzTnLPOUXxjNGKUda-HKvRGahqypqKqooy9qA4Z4LLUkpFH-YzF6zkNftyVlzEOFLKZKPU4-KsblsmuejOix9Xc3KTg7D0zngStwi4Jtc779KRmNmSafEImzeBwMEEAwmDi8lBJMtAJkwHB857N5cBY74wcyJ3yayHo19gAdgiMVvAPNxMDPlgVjNjRBIRltmacCRgApLBwK8nnxSPBuMjPr2fl8Xnt28-Xd-Utx_fvb--ui2haXkqJdSDUNJ0tuMD7WnbQM85U6qV3dAp0drB2tY0oldioCCoZbIWtGtQWWTY8svixUl3Dcu3DWPSk8ure59_t2xRM9kJ0Skluv-ANlTUSjU8Q-sTNPsZY8BBr8FNeUnNqN4z06PeM9N7ZpoqnTPLpOf3-ls_of1D-R1SBrw6ATAb8t1h0BEczoDWBYSk7eL-rf_6LzrkuBwY_xWPGMdlC3O2WjMda0313d6avTSsyYXJLvCf0jHAWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1750428853</pqid></control><display><type>article</type><title>Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility</title><source>ScienceDirect Freedom Collection</source><creator>Kimura, Yumiko ; Morinaga, Yoshitomo ; Akamatsu, Norihiko ; Matsuda, Junichi ; Yamaryo, Takeshi ; Kawakami, Kenji ; Matsuo, Hidenori ; Kosai, Kosuke ; Uno, Naoki ; Hasegawa, Hiroo ; Yanagihara, Katsunori</creator><creatorcontrib>Kimura, Yumiko ; Morinaga, Yoshitomo ; Akamatsu, Norihiko ; Matsuda, Junichi ; Yamaryo, Takeshi ; Kawakami, Kenji ; Matsuo, Hidenori ; Kosai, Kosuke ; Uno, Naoki ; Hasegawa, Hiroo ; Yanagihara, Katsunori</creatorcontrib><description>Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or secondary care facilities. A total of 128 MRSA isolates (90 skin and soft tissue isolates and 38 blood isolates) were collected at a secondary care facility, Kawatana Medical Center, from 2005 to 2011. Antimicrobial susceptibility testing for anti-MRSA antibiotics and molecular testing for SCC mec and virulence genes ( tst , sec , etb , luk S/F-PV) were performed. Strains positive for luk S/F-PV were analyzed by multilocus sequence typing and phage open-reading frame typing. SCC mec typing in skin and soft tissue isolates revealed that 65.6% had type IV, 22.2% had type II, 8.9% had type I, and 3.3% had type III. In blood isolates, 50.0% had type IV, 47.4% had type II, and 2.6% had type III. Minimum inhibitory concentrations, MIC50 /MIC90 , against vancomycin, teicoplanin, linezolid, and arbekacin increased slightly in SCC mec II isolates from skin and soft tissue. MICs against daptomycin were similar between sites of isolation. SCC mec type II isolates possess tst and sec genes at a greater frequently than SCC mec type IV isolates. Four luk S/F-PV-positive isolates were divided into two clonal patterns and USA300 was not included. In conclusion, SCC mec type IV was dominant in blood, skin, and soft tissue isolates in a secondary care facility in Japan. Because antimicrobial susceptibility varies with the SCC mec type, SCC mec typing of clinical isolates should be monitored in primary or secondary care facilities.</description><identifier>ISSN: 1341-321X</identifier><identifier>EISSN: 1437-7780</identifier><identifier>DOI: 10.1016/j.jiac.2015.08.011</identifier><identifier>PMID: 26617349</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Bacterial Proteins - blood ; Bacterial Toxins ; Community-acquired methicillin-resistant Staphylococcus aureus ; Cross Infection - blood ; Cross Infection - drug therapy ; Cross Infection - microbiology ; Daptomycin - therapeutic use ; Dibekacin - analogs & derivatives ; Dibekacin - therapeutic use ; Exotoxins ; Hematology, Oncology and Palliative Medicine ; Humans ; Japan ; Leukocidins ; Linezolid - therapeutic use ; Methicillin-Resistant Staphylococcus aureus - genetics ; Microbial Sensitivity Tests ; Multilocus Sequence Typing ; Open Reading Frames ; Panton-Valentine leukocidin ; Phage open reading frame typing ; Recombinases - blood ; SCCmec type ; Secondary Care Centers ; Skin - microbiology ; Soft Tissue Infections - microbiology ; Staphylococcus aureus ; Staphylococcus aureus - genetics ; Staphylococcus aureus - isolation & purification ; Teicoplanin - therapeutic use ; Vancomycin - therapeutic use ; Virulence Factors</subject><ispartof>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-01, Vol.22 (1), p.14-18</ispartof><rights>Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>Copyright © 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63</citedby><cites>FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26617349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kimura, Yumiko</creatorcontrib><creatorcontrib>Morinaga, Yoshitomo</creatorcontrib><creatorcontrib>Akamatsu, Norihiko</creatorcontrib><creatorcontrib>Matsuda, Junichi</creatorcontrib><creatorcontrib>Yamaryo, Takeshi</creatorcontrib><creatorcontrib>Kawakami, Kenji</creatorcontrib><creatorcontrib>Matsuo, Hidenori</creatorcontrib><creatorcontrib>Kosai, Kosuke</creatorcontrib><creatorcontrib>Uno, Naoki</creatorcontrib><creatorcontrib>Hasegawa, Hiroo</creatorcontrib><creatorcontrib>Yanagihara, Katsunori</creatorcontrib><title>Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility</title><title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</title><addtitle>J Infect Chemother</addtitle><description>Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or secondary care facilities. A total of 128 MRSA isolates (90 skin and soft tissue isolates and 38 blood isolates) were collected at a secondary care facility, Kawatana Medical Center, from 2005 to 2011. Antimicrobial susceptibility testing for anti-MRSA antibiotics and molecular testing for SCC mec and virulence genes ( tst , sec , etb , luk S/F-PV) were performed. Strains positive for luk S/F-PV were analyzed by multilocus sequence typing and phage open-reading frame typing. SCC mec typing in skin and soft tissue isolates revealed that 65.6% had type IV, 22.2% had type II, 8.9% had type I, and 3.3% had type III. In blood isolates, 50.0% had type IV, 47.4% had type II, and 2.6% had type III. Minimum inhibitory concentrations, MIC50 /MIC90 , against vancomycin, teicoplanin, linezolid, and arbekacin increased slightly in SCC mec II isolates from skin and soft tissue. MICs against daptomycin were similar between sites of isolation. SCC mec type II isolates possess tst and sec genes at a greater frequently than SCC mec type IV isolates. Four luk S/F-PV-positive isolates were divided into two clonal patterns and USA300 was not included. In conclusion, SCC mec type IV was dominant in blood, skin, and soft tissue isolates in a secondary care facility in Japan. Because antimicrobial susceptibility varies with the SCC mec type, SCC mec typing of clinical isolates should be monitored in primary or secondary care facilities.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacterial Proteins - blood</subject><subject>Bacterial Toxins</subject><subject>Community-acquired methicillin-resistant Staphylococcus aureus</subject><subject>Cross Infection - blood</subject><subject>Cross Infection - drug therapy</subject><subject>Cross Infection - microbiology</subject><subject>Daptomycin - therapeutic use</subject><subject>Dibekacin - analogs & derivatives</subject><subject>Dibekacin - therapeutic use</subject><subject>Exotoxins</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Japan</subject><subject>Leukocidins</subject><subject>Linezolid - therapeutic use</subject><subject>Methicillin-Resistant Staphylococcus aureus - genetics</subject><subject>Microbial Sensitivity Tests</subject><subject>Multilocus Sequence Typing</subject><subject>Open Reading Frames</subject><subject>Panton-Valentine leukocidin</subject><subject>Phage open reading frame typing</subject><subject>Recombinases - blood</subject><subject>SCCmec type</subject><subject>Secondary Care Centers</subject><subject>Skin - microbiology</subject><subject>Soft Tissue Infections - microbiology</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - genetics</subject><subject>Staphylococcus aureus - isolation & purification</subject><subject>Teicoplanin - therapeutic use</subject><subject>Vancomycin - therapeutic use</subject><subject>Virulence Factors</subject><issn>1341-321X</issn><issn>1437-7780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNUs2K1jAULaI4P_oCLiRLN61JkzYpiDAM6igDLkbBXUhvbvlS0x-TVPiewlc29RtduBBXN5BzTnLPOUXxjNGKUda-HKvRGahqypqKqooy9qA4Z4LLUkpFH-YzF6zkNftyVlzEOFLKZKPU4-KsblsmuejOix9Xc3KTg7D0zngStwi4Jtc779KRmNmSafEImzeBwMEEAwmDi8lBJMtAJkwHB857N5cBY74wcyJ3yayHo19gAdgiMVvAPNxMDPlgVjNjRBIRltmacCRgApLBwK8nnxSPBuMjPr2fl8Xnt28-Xd-Utx_fvb--ui2haXkqJdSDUNJ0tuMD7WnbQM85U6qV3dAp0drB2tY0oldioCCoZbIWtGtQWWTY8svixUl3Dcu3DWPSk8ure59_t2xRM9kJ0Skluv-ANlTUSjU8Q-sTNPsZY8BBr8FNeUnNqN4z06PeM9N7ZpoqnTPLpOf3-ls_of1D-R1SBrw6ATAb8t1h0BEczoDWBYSk7eL-rf_6LzrkuBwY_xWPGMdlC3O2WjMda0313d6avTSsyYXJLvCf0jHAWQ</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Kimura, Yumiko</creator><creator>Morinaga, Yoshitomo</creator><creator>Akamatsu, Norihiko</creator><creator>Matsuda, Junichi</creator><creator>Yamaryo, Takeshi</creator><creator>Kawakami, Kenji</creator><creator>Matsuo, Hidenori</creator><creator>Kosai, Kosuke</creator><creator>Uno, Naoki</creator><creator>Hasegawa, Hiroo</creator><creator>Yanagihara, Katsunori</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20160101</creationdate><title>Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility</title><author>Kimura, Yumiko ; Morinaga, Yoshitomo ; Akamatsu, Norihiko ; Matsuda, Junichi ; Yamaryo, Takeshi ; Kawakami, Kenji ; Matsuo, Hidenori ; Kosai, Kosuke ; Uno, Naoki ; Hasegawa, Hiroo ; Yanagihara, Katsunori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacterial Proteins - blood</topic><topic>Bacterial Toxins</topic><topic>Community-acquired methicillin-resistant Staphylococcus aureus</topic><topic>Cross Infection - blood</topic><topic>Cross Infection - drug therapy</topic><topic>Cross Infection - microbiology</topic><topic>Daptomycin - therapeutic use</topic><topic>Dibekacin - analogs & derivatives</topic><topic>Dibekacin - therapeutic use</topic><topic>Exotoxins</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Japan</topic><topic>Leukocidins</topic><topic>Linezolid - therapeutic use</topic><topic>Methicillin-Resistant Staphylococcus aureus - genetics</topic><topic>Microbial Sensitivity Tests</topic><topic>Multilocus Sequence Typing</topic><topic>Open Reading Frames</topic><topic>Panton-Valentine leukocidin</topic><topic>Phage open reading frame typing</topic><topic>Recombinases - blood</topic><topic>SCCmec type</topic><topic>Secondary Care Centers</topic><topic>Skin - microbiology</topic><topic>Soft Tissue Infections - microbiology</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - genetics</topic><topic>Staphylococcus aureus - isolation & purification</topic><topic>Teicoplanin - therapeutic use</topic><topic>Vancomycin - therapeutic use</topic><topic>Virulence Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kimura, Yumiko</creatorcontrib><creatorcontrib>Morinaga, Yoshitomo</creatorcontrib><creatorcontrib>Akamatsu, Norihiko</creatorcontrib><creatorcontrib>Matsuda, Junichi</creatorcontrib><creatorcontrib>Yamaryo, Takeshi</creatorcontrib><creatorcontrib>Kawakami, Kenji</creatorcontrib><creatorcontrib>Matsuo, Hidenori</creatorcontrib><creatorcontrib>Kosai, Kosuke</creatorcontrib><creatorcontrib>Uno, Naoki</creatorcontrib><creatorcontrib>Hasegawa, Hiroo</creatorcontrib><creatorcontrib>Yanagihara, Katsunori</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kimura, Yumiko</au><au>Morinaga, Yoshitomo</au><au>Akamatsu, Norihiko</au><au>Matsuda, Junichi</au><au>Yamaryo, Takeshi</au><au>Kawakami, Kenji</au><au>Matsuo, Hidenori</au><au>Kosai, Kosuke</au><au>Uno, Naoki</au><au>Hasegawa, Hiroo</au><au>Yanagihara, Katsunori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility</atitle><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle><addtitle>J Infect Chemother</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>22</volume><issue>1</issue><spage>14</spage><epage>18</epage><pages>14-18</pages><issn>1341-321X</issn><eissn>1437-7780</eissn><abstract>Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in Japan, and the Staphylococcus cassette chromosome mec (SCC mec ) type II is common among hospital-acquired MRSA isolates. Information pertaining to MRSA characteristics is limited, including SCC mec types, in primary or secondary care facilities. A total of 128 MRSA isolates (90 skin and soft tissue isolates and 38 blood isolates) were collected at a secondary care facility, Kawatana Medical Center, from 2005 to 2011. Antimicrobial susceptibility testing for anti-MRSA antibiotics and molecular testing for SCC mec and virulence genes ( tst , sec , etb , luk S/F-PV) were performed. Strains positive for luk S/F-PV were analyzed by multilocus sequence typing and phage open-reading frame typing. SCC mec typing in skin and soft tissue isolates revealed that 65.6% had type IV, 22.2% had type II, 8.9% had type I, and 3.3% had type III. In blood isolates, 50.0% had type IV, 47.4% had type II, and 2.6% had type III. Minimum inhibitory concentrations, MIC50 /MIC90 , against vancomycin, teicoplanin, linezolid, and arbekacin increased slightly in SCC mec II isolates from skin and soft tissue. MICs against daptomycin were similar between sites of isolation. SCC mec type II isolates possess tst and sec genes at a greater frequently than SCC mec type IV isolates. Four luk S/F-PV-positive isolates were divided into two clonal patterns and USA300 was not included. In conclusion, SCC mec type IV was dominant in blood, skin, and soft tissue isolates in a secondary care facility in Japan. Because antimicrobial susceptibility varies with the SCC mec type, SCC mec typing of clinical isolates should be monitored in primary or secondary care facilities.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>26617349</pmid><doi>10.1016/j.jiac.2015.08.011</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1341-321X |
ispartof | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-01, Vol.22 (1), p.14-18 |
issn | 1341-321X 1437-7780 |
language | eng |
recordid | cdi_proquest_miscellaneous_1794498849 |
source | ScienceDirect Freedom Collection |
subjects | Anti-Bacterial Agents - therapeutic use Bacterial Proteins - blood Bacterial Toxins Community-acquired methicillin-resistant Staphylococcus aureus Cross Infection - blood Cross Infection - drug therapy Cross Infection - microbiology Daptomycin - therapeutic use Dibekacin - analogs & derivatives Dibekacin - therapeutic use Exotoxins Hematology, Oncology and Palliative Medicine Humans Japan Leukocidins Linezolid - therapeutic use Methicillin-Resistant Staphylococcus aureus - genetics Microbial Sensitivity Tests Multilocus Sequence Typing Open Reading Frames Panton-Valentine leukocidin Phage open reading frame typing Recombinases - blood SCCmec type Secondary Care Centers Skin - microbiology Soft Tissue Infections - microbiology Staphylococcus aureus Staphylococcus aureus - genetics Staphylococcus aureus - isolation & purification Teicoplanin - therapeutic use Vancomycin - therapeutic use Virulence Factors |
title | Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T16%3A05%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20susceptibility%20and%20molecular%20characteristics%20of%20methicillin-resistant%20Staphylococcus%20aureus%20in%20a%20Japanese%20secondary%20care%20facility&rft.jtitle=Journal%20of%20infection%20and%20chemotherapy%20:%20official%20journal%20of%20the%20Japan%20Society%20of%20Chemotherapy&rft.au=Kimura,%20Yumiko&rft.date=2016-01-01&rft.volume=22&rft.issue=1&rft.spage=14&rft.epage=18&rft.pages=14-18&rft.issn=1341-321X&rft.eissn=1437-7780&rft_id=info:doi/10.1016/j.jiac.2015.08.011&rft_dat=%3Cproquest_cross%3E1794498849%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c563t-7c2f487a9d93f0b065cb33188679f9846dfdd6a54b84f0c40d1724095e8de1e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1750428853&rft_id=info:pmid/26617349&rfr_iscdi=true |